CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-23 | Klein Lawrence Otto Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +306,700 | 306,700 | ||
| 2026-01-23 | Quinlan Paul T General Counsel | Grant or award | +32,500 | 32,500 | ||
| 2026-01-23 | Quinlan Paul T General Counsel | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2026-01-23 | Dambkowski Carl Director | Other acquisition | +116,483 | 116,483 | ||
| 2026-01-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 5,018 |
| 2026-01-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 8,518 |
| 2026-01-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −4,381 | $31.56 | $138K | 4,137 |
| 2026-01-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −2,619 | $32.24 | $84K | 1,518 |
| 2026-01-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 221,563 | ||
| 2026-01-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 192,992 | ||
| 2026-01-02 | Sandler Laura Lee Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $7.80 | $39K | 218,084 |
| 2026-01-02 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −8,748 | $28.17 | $246K | 209,336 |
| 2026-01-02 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −3,144 | $29.08 | $91K | 206,192 |
| 2026-01-02 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −1,108 | $29.75 | $33K | 205,084 |
| 2026-01-02 | Sandler Laura Lee Chief Operating Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −5,000 | 94,996 | ||
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 5,018 |
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 8,518 |
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −641 | $28.53 | $18K | 7,877 |
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −1,787 | $29.62 | $53K | 6,090 |
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −1,492 | $30.70 | $46K | 4,598 |
Page 13 of 18 · 346 trades